The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Didier Tchétché

Showing 1-20 of 24 articles
Outcomes of valve-in-valve transcatheter aortic valve implantation with and without bioprosthetic valve fracture
Brinkmann C, Abdel-Wahab M, Bedogni F, Bhadra O, Charbonnier G, Conradi L, Hildick-Smith D, Kargoli F, Latib A, Van Mieghem N, Mylotte D, Landes U, Pilgrim T, Stripling J, Taramasso M, Tchétché D, Testa L, Thiele H, Webb J, Windecker S, Witt J, Wohlmuth P, Schofer J
November 19, 2021 | 10.4244/EIJ-D-21-00254
Interventions for valvular disease
Outcomes of Valve-in-Valve Transcatheter Aortic Valve Implantation with and without Bioprosthetic Valve Fracture
Brinkmann C, Abdel-Wahab M, Bedogni F, Bhadra OD, Charbonnier G, Conradi L, Hildick-Smith D, Kargoli F, Latib A, Van Mieghem N, Mylotte D, Landes U, Pilgrim T, Stripling J, Taramasso M, Tchétché D, Testa L, Thiele H, Webb J, Windecker S, Witt J, Wohlmuth P, Schofer J
May 25, 2021 | 10.4244/EIJ-D-21-00254
TAV-in-TAV for failed prosthesis: the new frontier
Tchétché D, Siddiqui S
June 12, 2020 | 10.4244/EIJV16I2A15
Interventions for valvular disease
Transcatheter mitral valve replacement: factors associated with screening success and failure
Coisne A, Pontana F, Tchétché D, Richardson M, Longère B, Vahdat O, Berthoumieu P, Van Belle E, Rousse N, Lancellotti P, Montaigne D, Dumonteil N, Modine T
December 6, 2019 | 10.4244/EIJ-D-19-00444
Improving our knowledge about a new plug-based vascular closure device
Tchétché D
May 20, 2019 | 10.4244/EIJV15I1A4
TAVI and the brain: update on definitions, evidence of neuroprotection and adjunctive pharmacotherapy
Lansky A, Ghare M, Tchétché D, Baumbach A
September 7, 2018 | 10.4244/EIJ-D-18-00454
Interventions for valvular disease
Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve
Kim U, Blanke P, Windecker S, Kasel M, Schäfer U, Walters D, Linke A, Le Breton H, Schymik G, Spence M, Søndergaard L, Abdel-Wahab M, Worthley S, Tchétché D, Reichenspurner H, Ohana M, Sellers S, Leipsic J
August 3, 2018 | 10.4244/EIJ-D-17-01040
Interventions for valvular disease
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Interventions for valvular disease
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
Interventions for valvular disease
The SURTAVI study: TAVI for patients with intermediate risk
Jones D, Tchétché D, Forrest J, Hellig F, Lansky A, Moat N
August 4, 2017 | 10.4244/EIJV13I5A97
Interventions for valvular disease
How should I treat a patient with a symptomatic and severe low-flow low-gradient aortic stenosis and an incidental abdominal aortic aneurysm?
Rahhab Z, Raa S, van der Ploeg N, Van Mieghem N, Verhagen H, de Jaegere P, Arsalan M, Kim W, Walther T, Tchétché D
July 20, 2017 | 10.4244/EIJ-D-16-00461
Interventions for valvular disease
Annulus rupture post transcatheter aortic valve implantation complicated by a giant pseudoaneurysm
Thimon T, Molina-Martin de Nicolas J, Lapeyre M, Tchétché D
February 3, 2017 | 10.4244/EIJ-D-16-00347
Interventions for valvular disease
A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis
Naber C, Pyxaras S, Ince H, Frambach P, Colombo A, Butter C, Gatto F, Hink U, Nickenig G, Bruschi G, Brueren G, Tchétché D, den Heijer P, Schillinger W, Scholtz S, Van der Heyden J, Lefèvre T, Gilard M, Kuck K, Schofer J, Divchev D, Baumgartner H, Asch F, Wagner M, Latib A, De Marco F, Kische S
December 9, 2016 | 10.4244/EIJ-D-15-00511
Interventions for valvular disease
Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy
Giustino G, van der Boon R, Molina-Martin de Nicolas J, Dumonteil N, Chieffo A, de Jaegere P, Tchétché D, Marcheix B, Millischer D, Cassagneau R, Carrié D, Van Mieghem N, Colombo A
October 20, 2016 | 10.4244/EIJV12I9A192
Interventions for valvular disease
Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 1: systematic measurement methodology and inter-observer variability
Thériault-Lauzier P, Mylotte D, Dorfmeister M, Spaziano M, Andalib A, Mamane S, Chetrit M, Blanke P, Cecere R, Buithieu J, Martucci G, Tchétché D, Modine T, Van Mieghem N, Lange R, Windecker S, Bilodeau L, Leipsic J, Piazza N
October 10, 2016 | 10.4244/EIJY15M11_09
Interventions for valvular disease
In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves
Simonato M, Azadani A, Webb J, Leipsic J, Kornowski R, Vahanian A, Wood D, Piazza N, Kodali S, Ye J, Whisenant B, Gaia D, Aziz M, Pasala T, Mehilli J, Wijeysundera H, Tchétché D, Moat N, Teles R, Petronio A, Hildick-Smith D, Landes U, Windecker S, Arbel Y, Mendiz O, Makkar R, Tseng E, Dvir D
September 18, 2016 | 10.4244/EIJV12I7A149
Interventions for valvular disease
TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery
van Gils L, Tchétché D, Latib A, Sgroi C, Manoharan G, Möllmann H, Van Mieghem N
September 18, 2016 | 10.4244/EIJV12SYA6
Interventions for valvular disease
Current decision making and short-term outcome in patients with degenerative aortic stenosis: the Pooled-RotterdAm-Milano-Toulouse In Collaboration Aortic Stenosis survey
Van Mieghem N, Dumonteil N, Chieffo A, Roux Y, van der Boon R, Giustino G, Hartman E, Aga Y, de Jong L, Ghanem M, Marcheix B, Cavazza C, Carrié D, Colombo A, Kappetein A, de Jaegere P, Tchétché D
February 12, 2016 | 10.4244/EIJV11I10A253
Interventions for valvular disease
Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report
Molina-Martin de Nicolas J, Tchétché D, Farah B
February 12, 2016 | 10.4244/EIJV11I11A255
New-generation TAVI devices: description and specifications
Tchétché D, Van Mieghem N
September 27, 2014 | 10.4244/EIJV10SUA13

Latest news

NEW ISSUE
PCR London Valves Edition: state of the art on transcatheter treatment for tricuspid valve disease, a mini focus on TR; coronary access after TAVI and more…
November 19, 2021
STATE OF THE ART
Transcatheter treatment for tricuspid valve disease
Fabien Praz et al.
November 19, 2021
AHEAD OF PRINT
Long-term impact of OCT-assessed suboptimal stent deployment
Francesco Prati et al.
November 25, 2021
EDITORIAL
Percutaneous tricuspid valve annuloplasty: additional data and remaining questions
Nicole Karam et al.
November 23, 2021
EDITORIAL
Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?
Josep Rodés-Cabau et al.
November 23, 2021
EDITORIAL
Understanding the past, getting prepared for the future. (Going from in vivo to in vitro to in silico)
Patrick W. Serruys
November 23, 2021
AHEAD OF PRINT
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Francesco Moroni et al.
November 18, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke